Categories Earnings, Technology

Okta tops Q2 2020 estimates; stock drops on weak Q3 outlook

Okta Inc’s (NASDAQ: OKTA) second quarter 2020 bottom line and top-line results surpassed market’s views. As expected, the company shrunk its loss. Non-GAAP loss per share was 5 cents on revenue of $140.5 million for the quarter ended July 31, 2019. Analysts had expected the cloud-based identity management company to post a loss of 10 cents per share on revenue of $131.18 million.

After trading in the positive territory for a while, Okta stock turned to red, hurt by weak bottom line outlook for Q3. Shares of Okta traded down about 3% at 4:45 PM ET.

When the the company reported first quarter 2020 results, it had projected second quarter 2020 revenue to be $130 million to $131 million and adjusted loss of $0.11 to $0.10 per share.

Okta Q2 2020 earnings results - Financial summary

Q2 revenue surged 49% year-over-year on strong subscription revenue growth of 51%. GAAP net loss was $43 million or $0.37 per share compared to a loss of $39.2 million or $0.37 per share in the second quarter of fiscal 2019.

For the third quarter of fiscal 2020, the company expects revenue to grow 35% to 36% to a range of $143 million to $144 million. Non-GAAP net loss per share is expected to be $0.13 to $0.12 whereas the market expected a loss of 9 cents per share.

Read: VMware (VMW) beats Q2 FY20 estimates; to acquire Pivotal Software and Carbon Black

Okta lifted its outlook for full-year 2020. The company now expects revenue of $560 to $563 million, representing a year-over-year growth rate of 40% to 41% and non-GAAP net loss per share of $0.44 to $0.42. This compares to the previous estimated revenue of $543 million to $548 million and non-GAAP loss per share outlook of $0.49 to $0.45.

The company had 7,000 customers at the end of second quarter of 2020, up 36% and customers with annual contract value (ACV) above $100,000 grew 46% year-over-year to 1,222.

The San Francisco, California-based firm’s shares, which reached its all-time high ($141.85) during the end of July, had surged 109% so far this year and 120% in the past 52 weeks.

Browse through our earnings calendar and get all scheduled earnings announcements, analyst/investor conference and much more!

Most Popular

IPO Alert: What to look for when Boundless Bio goes public

Boundless Bio is preparing to debut on the Nasdaq stock market this week, and become the latest addition to the list of biotech firms that have launched IPOs this year.

Nike (NKE) bets on innovation and partnerships to return to high growth

Sneaker giant Nike, Inc. (NYSE: NKE) has been going through a rough patch for some time, with sales coming under pressure from weak demand and rising competition. Post-pandemic, the company

Walgreens Boots Alliance set to report earnings next week. Here’s what to expect

Walgreens Boots Alliance, Inc. (NASDAQ: WBA), the drug store chain that is expanding into a diversified healthcare provider, is on a restructuring drive aimed at better aligning the business with

Add Comment
Loading...
Cancel
Viewing Highlight
Loading...
Highlight
Close
Top